Eli Lilly Nederland B.V. — China drug registrations and re-registration deadlines
32 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-01-19.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字SJ20171020 | Humalog Mix50 精蛋白锌重组赖脯胰岛素混合注射液(50R) | 2027-07-19 | 2027-01-19 |
| 国药准字SJ20171023 | Humalog Mix50 精蛋白锌重组赖脯胰岛素混合注射液(50R) | 2027-07-19 | 2027-01-19 |
| 国药准字HJ20171163 | Evista 盐酸雷洛昔芬片 | 2027-08-17 | 2027-02-17 |
| 国药准字HJ20220077 | Retsevmo 塞普替尼胶囊 | 2027-09-29 | 2027-03-29 |
| 国药准字HJ20220078 | Retsevmo 塞普替尼胶囊 | 2027-09-29 | 2027-03-29 |
| 国药准字SJ20230010 | BASAGLAR 甘精胰岛素注射液 | 2028-09-11 | 2028-03-11 |
| 国药准字SJ20230011 | BASAGLAR 甘精胰岛素注射液 | 2028-09-11 | 2028-03-11 |
| 国药准字SJ20230012 | LYUMJEV 赖脯胰岛素注射液（曲前） | 2028-09-18 | 2028-03-18 |
| 国药准字SJ20230013 | LYUMJEV 赖脯胰岛素注射液（曲前） | 2028-09-18 | 2028-03-18 |
| 国药准字HJ20240116 | Jaypirca 匹妥布替尼片 | 2028-10-21 | 2028-04-21 |
| 国药准字HJ20240117 | Jaypirca 匹妥布替尼片 | 2028-10-21 | 2028-04-21 |
| 国药准字SJ20190021 | TRULICITY 度拉糖肽注射液 | 2028-12-05 | 2028-06-05 |
| 国药准字SJ20190022 | TRULICITY 度拉糖肽注射液 | 2028-12-05 | 2028-06-05 |
| 国药准字SJ20240003 | Emgality 加卡奈珠单抗注射液 | 2029-01-04 | 2028-07-04 |
| 国药准字HJ20190039 | OLUMIANT 巴瑞替尼片 | 2029-04-28 | 2028-10-28 |
| 国药准字HJ20215001 | OLUMIANT 巴瑞替尼片 | 2029-04-28 | 2028-10-28 |
| 国药准字HJ20240020 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20240021 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20240022 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20240023 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20255004 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20255005 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20255006 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字HJ20255007 | MOUNJARO 替尔泊肽注射液 | 2029-05-14 | 2028-11-14 |
| 国药准字SJ20170014 | Humalog Mix25 精蛋白锌重组赖脯胰岛素混合注射液(25R) | 2029-07-21 | 2029-01-21 |
| 国药准字SJ20170032 | FORSTEO 特立帕肽注射液 | 2029-09-09 | 2029-03-09 |
| 国药准字HJ20140662 | Alimta 注射用培美曲塞二钠 | 2029-11-25 | 2029-05-25 |
| 国药准字HJ20150445 | Alimta 注射用培美曲塞二钠 | 2029-11-25 | 2029-05-25 |
| 国药准字SJ20160043 | Humalog Mix 25 精蛋白锌重组赖脯胰岛素混合注射液(25R) | 2030-09-24 | 2030-03-24 |
| 国药准字HJ20200067 | Verzenios 阿贝西利片 | 2030-11-09 | 2030-05-09 |
| 国药准字HJ20200068 | Verzenios 阿贝西利片 | 2030-11-09 | 2030-05-09 |
| 国药准字HJ20200069 | Verzenios 阿贝西利片 | 2030-11-09 | 2030-05-09 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.